The invention relates to a method for high-
throughput screening of a compound with Nrf2 activating activity. The method comprises the following steps: (1) establishing a
reporter gene containing three Nrf2 binding sites; (2) inserting the
reporter gene into plasmids, and thus obtaining
reporter gene plasmids; (3) amplifying the reporter
gene plasmids by adopting
escherichia coli, and purifying the plasmids; and (4) transfecting
HeLa cells by adopting the purified reporter
gene plasmids, and selecting stable expression
cell strains for the selection of an unknown compound. With the adoption of the technical scheme provided by the invention, the method for detecting the activating effect of Nrf2 in the prior art is enabled to adopt to the demand of high-
throughput screening at the initial development stage of the new
medicine. The traditional method generally needs half a day to two days for completely once of detection, while the quantity of the samples detected by the once experiment does not beyond a dozen. For the method provided by the invention, each 96-pore board can detect at least 10 samples, and the time needed for completing the detection by the 96-pore board is less than 30 minutes.